Insmed Inc. buy Wells Fargo & Company
Start price
20.10.25
/
50%
€143.00
Target price
20.10.26
€146.65
Performance (%)
-1.40%
Price
01.04.26
€142.00
Summary
This prediction is currently active. With a performance of -1.40%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 20.10.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 11.811% | 11.811% |
| iShares Core DAX® | 2,49 % | -5,94 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % |
| iShares S&P 500 | 1,35 % | -2,94 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $171.00 price target on the stock.
Ratings data for INSM provided by MarketBeat